ClinicalTrials.govpublic full text
Sasanlimab As Maintenance Treatment Based on Clinical Response to Neoadjuvant Treatment in Molecularly Categorized Muscle Invasive Bladder Cancer Patients
mibc, muscle invasive bladder cancer, sparing, cystectomy, gemcitabine, cisplatine, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 829741
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.